Cardiovascular disease: The price of a QALY--cost-effectiveness of statins in CKD

Nat Rev Nephrol. 2013 Jul;9(7):377-9. doi: 10.1038/nrneph.2013.104. Epub 2013 Jun 4.

Authors

Vivekanand Jha¹, Gopesh K Modi

Affiliation

¹ George Institute for Global Health, 219-221, Spelndor Forum, Jasola, New Delhi 110 025, India.

PMID: 23732458
DOI: 10.1038/nrneph.2013.104

No abstract available

Publication types

Comment

MeSH terms

Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / economics*
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Kidney Failure, Chronic / drug therapy*
Kidney Failure, Chronic / economics*
Male
Myocardial Infarction / economics*
Myocardial Infarction / prevention & control*
Pravastatin / economics*
Pravastatin / therapeutic use*
Rhabdomyolysis*
Stroke / economics*
Stroke / prevention & control*

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Pravastatin